Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-471
Closed -$251K 709
2020
Q4
$251K Buy
471
+20
+4% +$9.83K ﹤0.01% 519
2020
Q3
$217K Buy
451
+1
+0.2% +$490 ﹤0.01% 497
2020
Q2
$203K Buy
+450
New +$201K ﹤0.01% 508
2018
Q4
Sell
-839
Closed -$268K 498
2018
Q3
$268K Buy
+839
New +$267K ﹤0.01% 428
2018
Q2
Sell
-226
Closed -$62K 523
2018
Q1
$62K Hold
226
﹤0.01% 472
2017
Q4
$55K Hold
226
﹤0.01% 475
2017
Q3
$46K Buy
+226
New +$44.4K ﹤0.01% 447

Other funds holding CHE

Greenleaf Trust's CHE Position: Q1 2021 in Review

Greenleaf Trust sold out of Chemed (CHE) in Q1 2021, closing a stake of 471 shares — an estimated $251K sold.

Greenleaf Trust first reported a position in CHE in Q3 2017 and held it in 7 quarters. The position peaked at $268K in Q3 2018. 421 funds tracked by Wall St. Rank hold CHE as of Q1 2021.

  • Greenleaf Trust reported no remaining Chemed position as of Q1 2021 after selling out during the quarter.
  • Greenleaf Trust sold 471 Chemed shares in Q1 2021, an estimated $251K.
  • Greenleaf Trust first reported a position in Chemed in Q3 2017 and held it in 7 quarters.
  • Greenleaf Trust's Chemed position peaked at $268K in Q3 2018.
  • 421 funds tracked by Wall St. Rank held Chemed as of Q1 2021.

Based on Greenleaf Trust's 13F filing for Q1 2021, filed 30 Apr 2021.